Answers are grounded in this paper and cite their sources.
To longitudinally assess the impact of high-risk structural biomarkers for natural disease progression in non-exudative age-related macular degeneration (AMD) on spatially resolved mesopic and scotopic fundus-controlled perimetry testing.
No takes yet. Share an insight, caveat, or question.
Saßmannshausen et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: